PT3139948T - Treatment of diabetes type 1 using glp-1 and anti-il-21 - Google Patents
Treatment of diabetes type 1 using glp-1 and anti-il-21Info
- Publication number
- PT3139948T PT3139948T PT157209826T PT15720982T PT3139948T PT 3139948 T PT3139948 T PT 3139948T PT 157209826 T PT157209826 T PT 157209826T PT 15720982 T PT15720982 T PT 15720982T PT 3139948 T PT3139948 T PT 3139948T
- Authority
- PT
- Portugal
- Prior art keywords
- glp
- treatment
- diabetes type
- diabetes
- type
- Prior art date
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461989841P | 2014-05-07 | 2014-05-07 | |
EP14169596 | 2014-05-23 | ||
EP14189732 | 2014-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3139948T true PT3139948T (en) | 2020-05-22 |
Family
ID=70609983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT157209826T PT3139948T (en) | 2014-05-07 | 2015-05-05 | Treatment of diabetes type 1 using glp-1 and anti-il-21 |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP6824373B2 (en) |
DK (1) | DK3139948T3 (en) |
ES (1) | ES2791879T3 (en) |
HR (1) | HRP20200763T1 (en) |
HU (1) | HUE048860T2 (en) |
PT (1) | PT3139948T (en) |
-
2015
- 2015-05-05 PT PT157209826T patent/PT3139948T/en unknown
- 2015-05-05 HU HUE15720982A patent/HUE048860T2/en unknown
- 2015-05-05 DK DK15720982.6T patent/DK3139948T3/en active
- 2015-05-05 ES ES15720982T patent/ES2791879T3/en active Active
-
2019
- 2019-12-19 JP JP2019229235A patent/JP6824373B2/en active Active
-
2020
- 2020-05-11 HR HRP20200763TT patent/HRP20200763T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20200763T1 (en) | 2020-07-24 |
ES2791879T3 (en) | 2020-11-06 |
HUE048860T2 (en) | 2020-09-28 |
JP2020073501A (en) | 2020-05-14 |
JP6824373B2 (en) | 2021-02-03 |
DK3139948T3 (en) | 2020-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190369T1 (en) | Dihydrobenzofuran compounds useful in the treatment of diabetes and obesity | |
HK1243073A1 (en) | Therapeutic compounds and uses thereof | |
IL246757B (en) | Novel insulin derivatives and the medical uses hereof | |
HUE057301T2 (en) | Treatment of post-bariatric hypoglycemia with glp-1 antagonists | |
IL283335B (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
HK1244216A1 (en) | Treatment type 2 diabetes mellitus patients | |
GB201612165D0 (en) | Combinations for the treatment of type 2 diabetes | |
HK1251449A1 (en) | Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes | |
IL254500A0 (en) | Treatment of type 2 diabetes mellitus patients | |
GB201403996D0 (en) | Traditional chinese medicine composition for the treatment of diabetes | |
RS60316B1 (en) | Treatment of diabetes type 1 using glp-1 and anti-il-21 | |
HK1244821A1 (en) | Peptides for use in treatment and diagnosis of type 1 diabetes | |
GB201707207D0 (en) | Treatment of type 1 diabetes | |
IL250666B (en) | Peptide for treatment of type 2 diabetes mellitus and its complications | |
HK1257593A1 (en) | New drug for treating diabetes and use thereof | |
HUE048860T2 (en) | Treatment of diabetes type 1 using glp-1 and anti-il-21 | |
GB201513543D0 (en) | Compositions for use in the treatment of diabetes | |
GB201418541D0 (en) | Materials for use with general hyperthermia treatment | |
SG10201400823PA (en) | Therapeutic methods and compositions for treating diabetes | |
GB201417777D0 (en) | Novel compounds and therapeutic uses thereof |